Pelage Pharmaceuticals Raises $120 Million To Grow Hair Loss Program
The company is pursuing a Phase III trial for its topical stem cell-rejuvenating molecule that aims to reactivate hair growth.
Pelage Pharmaceuticals Raises $120 Million To Grow Hair Loss Program Read More »
